Kovai Medical

INR
5,022.65
-105.2 (-2.05%)
BSENSE

Mar 30

BSE+NSE Vol: 10.39 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

10.39 k (64.59%) Volume

Shareholding (Dec 2025)

FII

1.31%

Held by 63 FIIs

DII

1.27%

Held by 4 DIIs

Promoter

56.52%

When is the next results date for Kovai Medical?

06-Jun-2025

No Upcoming Board Meetings

Who are in the management team of Kovai Medical?

06-Jun-2025

As of March 2022, the management team of Kovai Medical includes Managing Director Nalla G Palaniswami, Joint Managing Director Thavamani Devi Palaniswami, and several directors, along with independent directors and Company Secretary R Ponmanikandan.

As of March 2022, the management team of Kovai Medical includes the following individuals:<BR><BR>1. Nalla G Palaniswami - Managing Director<BR>2. Thavamani Devi Palaniswami - Joint Managing Director<BR>3. Arun N Palaniswami - Whole-time Director<BR>4. M C Thirumoorthi - Director<BR>5. Purani P Palaniswami - Director<BR>6. Mohan S Gounder - Director<BR><BR>Additionally, the board comprises several independent directors:<BR><BR>1. Kasi K Goundan - Independent Director<BR>2. M Manickam - Independent Director<BR>3. A M Palanisamy - Independent Director<BR>4. K Saminathan - Independent Director<BR>5. R Bhuvaneshwari - Independent Director<BR>6. A P Ammasai Kutty - Independent Director<BR>7. K.Kolandaswamy - Independent Director<BR><BR>Lastly, R Ponmanikandan serves as the Company Secretary and Compliance Officer.

View full answer

What does Kovai Medical do?

06-Jun-2025

Kovai Medical Center and Hospital Ltd is a mid-cap multi-speciality hospital based in Coimbatore, established in 1985, with a recent net sales of ₹357 Cr and a net profit of ₹55 Cr as of March 2025. The company has a market cap of ₹6,678 Cr and key financial metrics include a P/E ratio of 32.00 and a return on equity of 23.52%.

Overview: <BR>Kovai Medical Center and Hospital Ltd operates as a multi-speciality hospital in the healthcare industry and is categorized as a mid-cap company.<BR><BR>History: <BR>The company was incorporated in 1985 and began its hospital operations in 1990 with a flagship 200-bed multi-speciality hospital in Coimbatore. As of the latest quarterly results reported for March 2025, the company has shown significant financial performance.<BR><BR>Financial Snapshot: <BR>- Net Sales: 357 Cr (Quarterly Results - Mar 2025) <BR>- Net Profit: 55 Cr (Quarterly Results - Mar 2025) <BR>- Market Cap: Rs 6,678 Cr (Mid Cap) <BR><BR>Key Metrics: <BR>- P/E: 32.00 <BR>- Industry P/E: 54 <BR>- Dividend Yield: 0.16% <BR>- Debt-Equity: 0.07 <BR>- Return on Equity: 23.52% <BR>- Price to Book: 7.55 <BR><BR>Contact Details: <BR>Address: 99 Avanashi Road, Coimbatore, Tamil Nadu: 641014 <BR>Tel: 91-422-4323800/3083800 <BR>Email: secretarialdept@kmchhospitals.com <BR>Website: http://www.kmchhospitals.com

View full answer

Has Kovai Medical declared dividend?

06-Jun-2025

Kovai Medical Center & Hospital Ltd has declared a 100% dividend, amounting to ₹10 per share, with an ex-date of August 1, 2024. The company has shown strong total returns over various periods, with a 5-year total return of 839.69%.

Kovai Medical Center & Hospital Ltd has declared a 100% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 100%<BR>- Amount per share: 10<BR>- Ex-date: 01 Aug 24<BR><BR>Dividend Yield: 0.16%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was 13.86%, with a dividend return of 0%, resulting in a total return of 13.86%.<BR><BR>Over the past year, the price return was 42.66%, the dividend return was 0.23%, leading to a total return of 42.89%.<BR><BR>For the 2-year period, the price return was 168.15%, the dividend return was 0.68%, culminating in a total return of 168.83%.<BR><BR>In the 3-year period, the price return was 327.22%, with a dividend return of 1.30%, resulting in a total return of 328.52%.<BR><BR>Over the last 4 years, the price return was 312.75%, the dividend return was 1.56%, leading to a total return of 314.31%.<BR><BR>In the 5-year period, the price return was 836.48%, with a dividend return of 3.21%, resulting in a total return of 839.69%.<BR><BR>Overall, Kovai Medical has declared a substantial dividend while also demonstrating impressive total returns across various periods, indicating strong financial performance and shareholder value enhancement.

View full answer

Who are the peers of the Kovai Medical?

03-Jun-2025

Kovai Medical's peers include Max Healthcare, Apollo Hospitals, Fortis Health, Narayana Hrudaya, Global Health, Yatharth Hospital, Indraprastha Medical, Artemis Medicare, and Dr. Agarwal's Eye. Among these, Max Healthcare and Apollo Hospitals show excellent management and growth, while Kovai Medical has below average growth and a good capital structure.

Peers: The peers of Kovai Medical are Max Healthcare, Apollo Hospitals, Fortis Health., Narayana Hrudaya, Global Health, Yatharth Hospit., Indrapr.Medical, Artemis Medicare, and Dr Agarwal's Eye.<BR><BR>Quality Snapshot: Excellent management risk is observed at Max Healthcare, Apollo Hospitals, Narayana Hrudaya, Global Health, and Indrapr.Medical, while Average management risk is found at Fortis Health., Yatharth Hospit., and Dr Agarwal's Eye, and the rest have Below Average management risk. Growth is Excellent at Max Healthcare and Apollo Hospitals, Good at Fortis Health., Narayana Hrudaya, Yatharth Hospit., and Indrapr.Medical, while Kovai Medical has Below Average growth and the rest have Below Average growth. Excellent capital structure is noted at Max Healthcare, Global Health, and Indrapr.Medical, while Average capital structure is found at Apollo Hospitals and Artemis Medicare, and Good capital structure is observed at Fortis Health., Kovai Medical, and Narayana Hrudaya, with the rest having Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Indrapr.Medical at 78.02%, while the lowest is Global Health at 4.29%. Kovai Medical's 1-year return of 46.73% is significantly higher than Global Health's but lower than Indrapr.Medical's. Additionally, Yatharth Hospit., Indrapr.Medical, Artemis Medicare, and Dr Agarwal's Eye have negative six-month returns.

View full answer

Who are the top shareholders of the Kovai Medical?

17-Jul-2025

The top shareholders of Kovai Medical include Kovai Purani Finance Private Limited with 36.96%, individual investors with 22.47%, and various institutional investors holding a total of 4.95%. Notably, there are no pledged promoter holdings.

The top shareholders of Kovai Medical include a mix of promoters and public investors. The majority of the shares are held by promoters, with Kovai Purani Finance Private Limited being the largest shareholder, owning 36.96% of the company. Additionally, individual investors collectively hold 22.47% of the shares. <BR><BR>In terms of institutional investors, there are 6 mutual fund schemes that hold a total of 3.67%, and 61 foreign institutional investors (FIIs) hold 1.28%. The highest public shareholder is Dsp Healthcare Fund, which has a holding of 1.63%. There are no pledged promoter holdings reported.

View full answer

How big is Kovai Medical?

24-Jul-2025

As of 24th July, Kovai Medical Center & Hospital Ltd has a market capitalization of 6,779.00 Cr, with recent Net Sales of 1,369.74 Cr and a Net Profit of 208.94 Cr.

As of 24th July, Kovai Medical Center & Hospital Ltd has a market capitalization of 6,779.00 Cr, categorizing it as a Mid Cap company.<BR><BR>In the latest four quarters, Kovai Medical reported Net Sales of 1,369.74 Cr and a Net Profit of 208.94 Cr.<BR><BR>The latest annual period for the balance sheet is March 2018, with Shareholder's Funds amounting to 288.56 Cr and Total Assets valued at 606.12 Cr.

View full answer

Is Kovai Medical overvalued or undervalued?

11-Nov-2025

As of November 10, 2025, Kovai Medical is considered very attractive in valuation, with a PE ratio of 29.89, an EV to EBITDA of 16.66, and a ROE of 21.05%, significantly lower than peers like Max Healthcare and Apollo Hospitals, while also outperforming the Sensex with an 11.59% return compared to its 5.09%.

As of 10 November 2025, Kovai Medical has moved from an attractive to a very attractive valuation grade. The company appears to be undervalued based on its current metrics. Key ratios include a PE ratio of 29.89, an EV to EBITDA of 16.66, and a ROE of 21.05%. <BR><BR>In comparison to its peers, Kovai Medical's PE ratio is significantly lower than that of Max Healthcare, which stands at 88.71, and Apollo Hospitals at 64.78, indicating a more favorable valuation. The company's recent stock performance has outpaced the Sensex over the last year, returning 11.59% compared to the Sensex's 5.09%, reinforcing the attractiveness of its current valuation.

View full answer

How has been the historical performance of Kovai Medical?

02-Dec-2025

Kovai Medical's historical performance from March 2013 to March 2018 shows strong growth in net sales from 297.01 Cr to 585.51 Cr, with total operating income reaching 592.37 Cr and profit after tax at 57.98 Cr. Despite rising expenditures and total liabilities of 606.12 Cr, the company maintained positive cash flow and a solid earnings per share of 52.99.

Answer:<BR>The historical performance of Kovai Medical shows a consistent growth trajectory in net sales, with figures rising from 297.01 Cr in March 2013 to 585.51 Cr in March 2018. Other operating income also increased, albeit from a negligible amount in earlier years to 6.85 Cr by March 2018. Total operating income followed a similar upward trend, reaching 592.37 Cr in March 2018. The company's total expenditure, excluding depreciation, rose to 463.26 Cr in March 2018, reflecting increased operational costs. Operating profit, excluding other income, was 129.11 Cr in March 2018, with a slight decrease in the operating profit margin to 21.79%. Profit before tax peaked at 89.44 Cr in March 2018, while profit after tax was recorded at 57.98 Cr, showing a slight decline from the previous year. The earnings per share (EPS) was 52.99, with a book value per share of 263.71. On the balance sheet, total liabilities increased to 606.12 Cr, driven by long-term borrowings of 164.56 Cr. Total assets also grew to 606.12 Cr, with cash and cash equivalents at 23.68 Cr by March 2018, indicating a positive cash flow trend despite a significant outflow from investing activities.<BR><BR>Breakdown:<BR>Kovai Medical's financial performance from March 2013 to March 2018 illustrates robust growth in net sales, which increased from 297.01 Cr to 585.51 Cr, alongside a rise in other operating income to 6.85 Cr. Total operating income reached 592.37 Cr, while total expenditure climbed to 463.26 Cr, reflecting the company's expanding operations. Operating profit, excluding other income, was 129.11 Cr, with a slight decrease in the operating profit margin to 21.79%. Profit before tax was 89.44 Cr, and profit after tax was 57.98 Cr, indicating a minor decline from the previous year. The earnings per share stood at 52.99, and the book value per share increased to 263.71. On the balance sheet, total liabilities rose to 606.12 Cr, primarily due to long-term borrowings of 164.56 Cr, while total assets matched this figure, with cash and cash equivalents at 23.68 Cr, reflecting a positive cash flow despite significant investment outflows.

View full answer

Is Kovai Medical technically bullish or bearish?

04-Dec-2025

As of December 3, 2025, Kovai Medical's trend has shifted to mildly bearish, supported by bearish signals from the MACD, KST, and Dow Theory, despite some mildly bullish indications from daily moving averages.

As of 3 December 2025, the technical trend for Kovai Medical has changed from mildly bullish to mildly bearish. The current stance is mildly bearish, driven by the weekly and monthly MACD and KST indicators, both indicating a bearish outlook. The Dow Theory also supports this bearish sentiment on both weekly and monthly time frames. While the daily moving averages show a mildly bullish signal, the overall trend is overshadowed by the bearish signals from the weekly Bollinger Bands and the lack of strong signals from the RSI. The recent price action reflects a decline from the previous close, further confirming the bearish trend.

View full answer

Are Kovai Medical Center & Hospital Ltd latest results good or bad?

07-Feb-2026

Kovai Medical Center & Hospital Ltd's latest Q3 FY26 results are positive, with a net profit of ₹65.02 crores and a revenue increase of 4.06% quarter-on-quarter. However, the stock is currently trading 19.81% below its 52-week high, indicating some caution despite strong fundamentals.

Kovai Medical Center & Hospital Ltd's latest results for Q3 FY26 indicate a positive performance overall. The company reported a net profit of ₹65.02 crores, which reflects a 12.49% increase quarter-on-quarter and a significant year-on-year growth. Revenue also saw a healthy increase, with net sales reaching ₹406.62 crores, marking a 4.06% growth from the previous quarter and a 14.64% increase compared to the same quarter last year.<BR><BR>The operating margin improved to 28.52%, up by 113 basis points from the previous quarter, showcasing effective cost management and operational efficiency. Additionally, the return on equity (ROE) stands strong at 19.21%, indicating good capital efficiency.<BR><BR>Despite these positive results, the stock has faced challenges, trading 19.81% below its 52-week high and underperforming compared to its sector peers over the past year. However, the company's solid fundamentals and consistent revenue growth suggest that it remains a fundamentally sound player in the healthcare sector.<BR><BR>In summary, while the latest results are strong and reflect good operational execution, the stock's recent underperformance and market conditions present some caution for investors.

View full answer

Should I buy, sell or hold Kovai Medical Center & Hospital Ltd?

07-Feb-2026

Why is Kovai Medical Center & Hospital Ltd falling/rising?

26-Mar-2026

As of 26-Mar, Kovai Medical Center & Hospital Ltd's stock price is Rs 5,175.00, reflecting a decline of 0.64% and underperforming the market. Despite strong fundamentals, the stock has shown a flat performance over the past year and is currently trading below key moving averages, indicating a bearish trend.

As of 26-Mar, Kovai Medical Center & Hospital Ltd's stock price is falling, currently at Rs 5,175.00, reflecting a decrease of Rs 33.35 or 0.64%. The stock has underperformed relative to the broader market, with a 1-week decline of 2.34% compared to the Sensex's decline of 1.87%. Over the past month, the stock has also shown a slight decrease of 0.17%, while the Sensex has dropped by 8.51%.<BR><BR>Today's trading activity indicates that the stock is close to its 52-week low, being only 2.42% away from Rs 5,049.8. The stock reached an intraday high of Rs 5,329.95 but also touched a low of Rs 5,062.30, indicating volatility within the trading day. Furthermore, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend.<BR><BR>Investor participation appears to be declining, as evidenced by a drop in delivery volume by 8.37% against the 5-day average. Despite the Hospital & Healthcare Services sector gaining by 2.27%, Kovai Medical has underperformed its sector by 2.91%. <BR><BR>While the company has strong fundamentals, including a high return on capital employed (ROCE) of 20.78% and a low debt-to-EBITDA ratio of 0.99, these positive factors have not translated into stock price appreciation in the short term. The stock's performance over the past year has been relatively flat, with a return of -0.25%, despite a 14.2% increase in profits. This combination of factors contributes to the current downward pressure on the stock price.

View full answer

Why is Kovai Medical Center & Hospital Ltd falling/rising?

27-Mar-2026

As of 27-Mar, Kovai Medical Center & Hospital Ltd's stock price is declining, currently at 5,135.00, reflecting a bearish trend with a total decline of -1.41% over the last two days and underperformance against the Sensex. Despite some positive indicators, the stock is close to its 52-week low and has decreased by -0.87% over the year, raising valuation concerns among investors.

As of 27-Mar, Kovai Medical Center & Hospital Ltd's stock price is falling, currently at 5,135.00, reflecting a decrease of 55.1 (-1.06%). The stock has been on a downward trend, having lost value for the last two consecutive days, resulting in a total decline of -1.41% during this period. Additionally, the stock is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend.<BR><BR>In the past week, the stock has underperformed compared to the benchmark Sensex, with a decline of -2.54% against the Sensex's -1.27%. Over the past month, the stock has also decreased by -2.88%, while the Sensex has dropped by -9.48%, suggesting that despite the overall market downturn, Kovai Medical has not fared well. Furthermore, the stock is close to its 52-week low, just 1.66% away from Rs 5049.8.<BR><BR>Despite some positive indicators, such as rising investor participation with a 49.7% increase in delivery volume and strong management efficiency reflected in a high ROCE of 20.78%, these factors have not been sufficient to counteract the recent price declines. The stock's performance over the year shows a slight decrease of -0.87%, even as profits have risen by 14.2%, indicating potential valuation concerns among investors. Overall, the combination of recent price declines, underperformance against benchmarks, and proximity to a 52-week low contributes to the stock's current downward trajectory.

View full answer

Why is Kovai Medical Center & Hospital Ltd falling/rising?

28-Mar-2026

As of 28-Mar, Kovai Medical Center & Hospital Ltd's stock price is Rs 5,135.00, down 1.06% and on a downward trend. Despite recent declines, the stock has shown significant long-term growth and outperformed its sector today, although it is trading below key moving averages and close to its 52-week low.

As of 28-Mar, Kovai Medical Center & Hospital Ltd's stock price is falling, currently at Rs 5,135.00, reflecting a decrease of Rs 55.1 or 1.06%. The stock has been on a downward trend, having lost value for the last two days, with a total decline of 1.41% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend.<BR><BR>In the broader context, the stock has underperformed compared to the benchmark Sensex over various periods, including a 1-week decline of 2.54% against the Sensex's 1.27% drop and a 1-month decline of 2.88% compared to the Sensex's 9.48% decline. Despite this, the stock has shown resilience over the longer term, with a 3-year increase of 178.10% and a 5-year increase of 373.56%. <BR><BR>The stock is also close to its 52-week low, being only 1.66% away from Rs 5,049.8. However, there is a positive aspect as the stock has outperformed its sector by 0.52% today, and there has been a notable increase in investor participation, with delivery volume rising by 49.7% against the 5-day average.<BR><BR>Overall, while the stock has strong fundamentals, including high management efficiency and a low debt-to-EBITDA ratio, the recent price movements reflect a short-term decline influenced by market conditions and trading patterns.

View full answer

Why is Kovai Medical Center & Hospital Ltd falling/rising?

29-Mar-2026

As of 29-Mar, Kovai Medical Center & Hospital Ltd's stock price is Rs 5,135.00, down 1.06%, and is trading below all key moving averages while nearing its 52-week low. Despite recent declines and underperformance against the Sensex, the company maintains strong fundamentals, suggesting the price drop may be temporary.

As of 29-Mar, Kovai Medical Center & Hospital Ltd's stock price is falling, currently at Rs 5,135.00, which reflects a decrease of Rs 55.1 or 1.06%. The stock has been on a downward trend, having lost 1.41% over the last two days and is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the stock is close to its 52-week low, just 1.66% away from Rs 5,049.8.<BR><BR>In terms of performance relative to the market, the stock has underperformed the Sensex over the past week and month, with declines of 2.54% and 2.88%, respectively. Year-to-date, the stock has fallen by 10.72%, although it has outperformed the sector today by 0.52%. Despite these recent declines, the company shows strong fundamentals, including a high return on capital employed (ROCE) of 20.78% and a low debt-to-EBITDA ratio of 0.99 times, indicating good management efficiency and a strong ability to service debt.<BR><BR>Overall, while the stock is experiencing a decline in price, it is supported by solid operational metrics and a healthy long-term growth outlook, which may suggest that the current price drop could be temporary.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

High Management Efficiency with a high ROCE of 20.78%

 
2

Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.96 times

 
3

Healthy long term growth as Operating profit has grown by an annual rate 25.70%

4

With ROE of 19.8, it has a Attractive valuation with a 4.6 Price to Book Value

5

Majority shareholders : Promoters

 
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Hospital

stock-summary
Market cap

INR 5,619 Cr (Small Cap)

stock-summary
P/E

23.00

stock-summary
Industry P/E

55

stock-summary
Dividend Yield

0.19%

stock-summary
Debt Equity

0.08

stock-summary
Return on Equity

19.81%

stock-summary
Price to Book

4.72

Revenue and Profits:
Net Sales:
407 Cr
(Quarterly Results - Dec 2025)
Net Profit:
65 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.19%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-12.93%
0%
-12.93%
6 Months
-18.1%
0%
-18.1%
1 Year
-4.24%
0.18%
-4.06%
2 Years
34.23%
0.51%
34.74%
3 Years
169.69%
1.26%
170.95%
4 Years
211.67%
1.62%
213.29%
5 Years
357.14%
2.51%
359.65%

Latest dividend: 10 per share ex-dividend date: Aug-14-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Closure of Trading Window

19-Mar-2026 | Source : BSE

The Trading Window for trading in Companys Securities shall remain closed from 1st April 2026 till the end of 48 hours after the declaration of Audited Financial Results for the Quarter / Year ended 31st March 2026 for insiders designated persons and their immediate relative.

Announcement under Regulation 30 (LODR)-Newspaper Publication

11-Mar-2026 | Source : BSE

We herewith enclose the copies of Newspaper Advertisement published in English and Tamil on 11.03.2026 with regard to the Postal ballot Notice to Shareholders.

Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

10-Mar-2026 | Source : BSE

We enclose herewith the the Postal ballot Notice for seeking approval of members to approve the Reappointment of Mr.A.P.Ammasaikutti and Dr.K.Kolandaswamy as Independent Directors of the Company for the second term of 5 years.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Kovai Medical Center & Hospital Ltd has declared 100% dividend, ex-date: 14 Aug 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
17.98%
EBIT Growth (5y)
25.70%
EBIT to Interest (avg)
6.61
Debt to EBITDA (avg)
1.89
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
0.90
Tax Ratio
25.32%
Dividend Payout Ratio
6.09%
Pledged Shares
0
Institutional Holding
6.04%
ROCE (avg)
19.71%
ROE (avg)
19.55%

Valuation key factors

Factor
Value
P/E Ratio
23
Industry P/E
55
Price to Book Value
4.62
EV to EBIT
17.19
EV to EBITDA
13.00
EV to Capital Employed
4.36
EV to Sales
3.65
PEG Ratio
1.64
Dividend Yield
0.20%
ROCE (Latest)
24.59%
ROE (Latest)
19.81%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 7 Schemes (3.46%)

FIIs

Held by 63 FIIs (1.31%)

Promoter with highest holding

Kovai Purani Finance Private Limited (36.97%)

Highest Public shareholder

Dsp Healthcare Fund (1.63%)

Individual Investors Holdings

22.34%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 4.06% vs 4.59% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 10.47% vs 2.85% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "406.62",
          "val2": "390.74",
          "chgp": "4.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "115.95",
          "val2": "107.01",
          "chgp": "8.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8.42",
          "val2": "8.74",
          "chgp": "-3.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "65.02",
          "val2": "58.86",
          "chgp": "10.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "28.52%",
          "val2": "27.39%",
          "chgp": "1.13%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 16.09% vs 14.17% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 20.38% vs 29.52% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "764.33",
          "val2": "658.41",
          "chgp": "16.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "212.81",
          "val2": "181.77",
          "chgp": "17.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "17.91",
          "val2": "14.87",
          "chgp": "20.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "116.09",
          "val2": "96.44",
          "chgp": "20.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "27.84%",
          "val2": "27.61%",
          "chgp": "0.23%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 15.58% vs 12.88% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 17.42% vs 20.92% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,170.95",
          "val2": "1,013.11",
          "chgp": "15.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "328.76",
          "val2": "284.67",
          "chgp": "15.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "26.33",
          "val2": "24.03",
          "chgp": "9.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "181.11",
          "val2": "154.24",
          "chgp": "17.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "28.03%",
          "val2": "28.07%",
          "chgp": "-0.04%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 12.43% vs 19.61% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 16.26% vs 55.25% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,369.74",
          "val2": "1,218.27",
          "chgp": "12.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "385.72",
          "val2": "341.69",
          "chgp": "12.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "32.68",
          "val2": "32.94",
          "chgp": "-0.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "208.95",
          "val2": "179.73",
          "chgp": "16.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "28.16%",
          "val2": "28.05%",
          "chgp": "0.11%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
406.62
390.74
4.06%
Operating Profit (PBDIT) excl Other Income
115.95
107.01
8.35%
Interest
8.42
8.74
-3.66%
Exceptional Items
0.00
0.00
Standalone Net Profit
65.02
58.86
10.47%
Operating Profit Margin (Excl OI)
28.52%
27.39%
1.13%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 4.06% vs 4.59% in Sep 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is 10.47% vs 2.85% in Sep 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
764.33
658.41
16.09%
Operating Profit (PBDIT) excl Other Income
212.81
181.77
17.08%
Interest
17.91
14.87
20.44%
Exceptional Items
0.00
0.00
Standalone Net Profit
116.09
96.44
20.38%
Operating Profit Margin (Excl OI)
27.84%
27.61%
0.23%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 16.09% vs 14.17% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is 20.38% vs 29.52% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
1,170.95
1,013.11
15.58%
Operating Profit (PBDIT) excl Other Income
328.76
284.67
15.49%
Interest
26.33
24.03
9.57%
Exceptional Items
0.00
0.00
Standalone Net Profit
181.11
154.24
17.42%
Operating Profit Margin (Excl OI)
28.03%
28.07%
-0.04%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 15.58% vs 12.88% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 17.42% vs 20.92% in Dec 2024

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
1,369.74
1,218.27
12.43%
Operating Profit (PBDIT) excl Other Income
385.72
341.69
12.89%
Interest
32.68
32.94
-0.79%
Exceptional Items
0.00
0.00
Standalone Net Profit
208.95
179.73
16.26%
Operating Profit Margin (Excl OI)
28.16%
28.05%
0.11%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 12.43% vs 19.61% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is 16.26% vs 55.25% in Mar 2024

stock-summaryCompany CV
About Kovai Medical Center & Hospital Ltd stock-summary
stock-summary
Kovai Medical Center & Hospital Ltd
Small Cap
Hospital
Kovai Medical Center and Hospital Limited was incorporated as a Public Company in year 1985 and commenced its hospital operation in year 1990 with the flagship of Multi-Speciality Hospital at Coimbatore with a capacity of 200 Bed Hospital. Thereafter, the Hospital set up the satellite centers at Coimbatore in the name of City Center, Sulur Hospital and Kovilpalayam Hospital and Erode in the name of Erode Speciality Hospital.
Company Coordinates stock-summary
Company Details
99 Avanashi Road , Coimbatore Tamil Nadu : 641014
stock-summary
Tel: 91-422-4323800/3083800
stock-summary
secretarialdept@kmchhospitals.com/a
Registrar Details
GNSA Investor Services (P) Ltd , G R Mansion, 11 Srinivasan Road, Pondy Bazaar T Nagar , Chennai